John Osth
Director Ejecutivo en QuantumCor, Inc. .
Perfil
John Osth is the founder of QuantumCor, Inc. which was founded in 2002.
He is currently the President & Chief Executive Officer at NanoSomiX, Inc., a Director at Miragene Corp., a Director at The Marrow Foundation, and the Chief Operating Officer at Hematologics, Inc. Mr. Osth was previously the President & Chief Executive Officer at Celula, Inc., a Director at Chemokine Therapeutics Corp.
from 2003 to 2007, and the President-Immunotherapy Division at Baxter Healthcare Corp.
He was also a General Partner at Desert Trail Consulting LLC.
Mr. Osth received an MBA degree from The University of Chicago in 1978, an undergraduate degree from United States Naval Academy, and a graduate degree from the University of Illinois.
Cargos activos de John Osth
| Empresas | Cargo | Inicio |
|---|---|---|
QuantumCor, Inc.
 QuantumCor, Inc. Medical SpecialtiesHealth Technology QuantumCor, Inc. is a medical device company developing Transcatheter Mitral Valve Repair (TMVR) technologies. The company was founded by John Osth and is headquartered in Laguna Hills, CA. | Director Ejecutivo | 01/01/2002 |
| Miragene Corp. | Director/Miembro de la Junta | - |
| Hematologics, Inc. | Director de Operaciones | - |
| The Marrow Foundation | Director/Miembro de la Junta | - |
NanoSomiX, Inc.
 NanoSomiX, Inc. BiotechnologyHealth Technology NanoSomiX, Inc. is a company that specializes in non-invasive testing using brain-derived exosomes (BDE) to improve brain analytic tools for research and clinical applications. The company is based in Aliso Viejo, CA, and the CEO of the company is John Osth. BDEs are small vesicles that carry brain-produced biomarkers related to brain function and are released into the bloodstream. The company works with academic researchers and commercial companies to support ongoing research into biomarkers associated with various neurologic disorders and neurotrauma. The company provides a blood-based assay that is repeatable, cost-effective, and fits easily into a routine diagnostic or research environment. | Director Ejecutivo | - |
Antiguos cargos conocidos de John Osth.
| Empresas | Cargo | Fin |
|---|---|---|
Chemokine Therapeutics Corp.
 Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | Director/Miembro de la Junta | 14/12/2007 |
Celula, Inc.
 Celula, Inc. Medical/Nursing ServicesHealth Services Celula, Inc. provides diagnostic testing services. It develops innovative instruments for clinical diagnostics and biomedical research using advanced micro fluidics and other technologies. The company was founded in May 2005 by Philippe J. Marchand, Andy Katz and Haichuan Zhang and is headquartered in San Diego, CA. | Director Ejecutivo | - |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | - |
| Desert Trail Consulting LLC | Corporate Officer/Principal | - |
Formación de John Osth.
| The University of Chicago | Masters Business Admin |
| University of Illinois | Graduate Degree |
| United States Naval Academy | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 9 |
|---|---|
Chemokine Therapeutics Corp.
Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | Health Technology |
QuantumCor, Inc.
QuantumCor, Inc. Medical SpecialtiesHealth Technology QuantumCor, Inc. is a medical device company developing Transcatheter Mitral Valve Repair (TMVR) technologies. The company was founded by John Osth and is headquartered in Laguna Hills, CA. | Health Technology |
| Desert Trail Consulting LLC | |
| Miragene Corp. | |
| Hematologics, Inc. | |
| The Marrow Foundation | |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
Celula, Inc.
Celula, Inc. Medical/Nursing ServicesHealth Services Celula, Inc. provides diagnostic testing services. It develops innovative instruments for clinical diagnostics and biomedical research using advanced micro fluidics and other technologies. The company was founded in May 2005 by Philippe J. Marchand, Andy Katz and Haichuan Zhang and is headquartered in San Diego, CA. | Health Services |
NanoSomiX, Inc.
NanoSomiX, Inc. BiotechnologyHealth Technology NanoSomiX, Inc. is a company that specializes in non-invasive testing using brain-derived exosomes (BDE) to improve brain analytic tools for research and clinical applications. The company is based in Aliso Viejo, CA, and the CEO of the company is John Osth. BDEs are small vesicles that carry brain-produced biomarkers related to brain function and are released into the bloodstream. The company works with academic researchers and commercial companies to support ongoing research into biomarkers associated with various neurologic disorders and neurotrauma. The company provides a blood-based assay that is repeatable, cost-effective, and fits easily into a routine diagnostic or research environment. | Health Technology |
- Bolsa de valores
- Insiders
- John Osth
